Gilphex
Product Images NDC 66576-336

1 FDA label image from Syntho Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Gilphex (NDC 66576-336). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Syntho Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Gliphex 100s Bottle Label)

Image Description (Gliphex 100s Bottle Label)
Drug Facts panel for Gilphex Total Release Expectorant Nasal Decongestant Tablets details active ingredients guaifenesin (390 mg) and phenylephrine HCl (10 mg). It includes uses, warnings, directions, inactive ingredients, storage instructions, and a contact phone number for questions. Manufactured for Gil Pharmaceutical Corp., Ponce, Puerto Rico.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.